UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐
Soliciting Material Pursuant to §240.14a-12

 

CORBUS PHARMACEUTICALS HOLDINGS, INC.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

 

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required.

☐
Fee paid previously with preliminary materials
☐
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

img192851997_0.jpg

 

 

 

 

img192851997_1.jpg

 

Corbus Pharmaceuticals (NASDAQ:CRBP)
과거 데이터 주식 차트
부터 5월(5) 2025 으로 6월(6) 2025 Corbus Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Corbus Pharmaceuticals (NASDAQ:CRBP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 6월(6) 2025 Corbus Pharmaceuticals 차트를 더 보려면 여기를 클릭.